SPAC

Calidi Biotherapeutics, SPAC, cell therapy, allogeneic, off-the-shelf treatment, Special purpose acquisition company, M&A

Calidi Biotherapeutics goes public through SPAC deal to advance off-the-shelf cancer treatments

Anika Sharma

Calidi Biotherapeutics, a San Diego-based biotech, has chosen the special purpose acquisition company (SPAC) path to enter the public market, ...

Biotechnology, Cell and gene therapy, Nobel Prize, Special purpose acquisition company, SPAC

Nobel Prize Winnerโ€™s Biotech Company Escapes the Graveyard with SPAC

Anika Sharma

Reviving a Silent Spell: Celixir, a UK-based cell therapy biotech, emerges from the shadows with a transformative move. Following a ...